Bezlotoxumab Not Yet Recruiting Phase 2 Trials for Clostridium Difficile Infection (CDI) / Inflammatory Bowel Diseases (IBD) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03829475ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI